News in brief: MDMA-analogues to be tested as neurological treatment; ‘First brain’ theory supported for enteric nervous system, Long COVID uncommon in children, research finds

Drug developer looks to trip over new MDMA-like treatment Next generation neurological treatments could come from the University of Western Australia’s (UWA) MDMA analogue library, according to a healthcare technology and drug development company. Emyria has secured the rights to over 100 MDMA analogues and will pay $491,000 over 12 months to help determine their ...

Already a member?

Login to keep reading.

© 2021 the limbic